MEDTRONIC PUERTO RICO OPERATIONS CO. 630G INSULIN PUMP MMT-1715K 630G BLACK MG; ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND
|
Back to Search Results |
|
Model Number MMT-1715K |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hyperglycemia (1905); Dizziness (2194); Diabetic Ketoacidosis (2364)
|
Event Date 03/29/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.
|
|
Event Description
|
The customer reported via phone call that they were hospitalized for high blood glucose on (b)(6) 2022.The customer blood glucose level was over 400 mg/dl which leads to the hospitalization.Current blood glucose level was 202 mg/dl.Customer did experienced symptoms because of high blood glucose such as sickness and dizziness.Customer test for ketones and test result was positive.Customer was treated with insulin drip.The customer had been using insulin pump system within 48 hours of reported high blood glucose event with auto mode off.Troubleshooting was successfully performed and the customer will continue use of the device.
|
|
Manufacturer Narrative
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.The information provided with initial mdr was incorrect.The correct information has been updated in b5 section of this report.
|
|
Event Description
|
It was reported that customer reported they were in hospitalized on (b)(6) 2022 at 17:00 for high blood glucose over 400mg/dl and diabetic ketoacidosis.Customer was feeling sick/unwell and was dizzy.Customer did not give the result of the ketones test.Insulin pump was used at the time of the incident.Customer uses competitor's sensor.Insulin pump does not have auto mode feature.Doctor advised her not to use the insulin pump anymore.They are getting a replacement.
|
|
Manufacturer Narrative
|
This complaint is related to litigation and legal restrictions which do not currently allow completion of product analysis.The complaint is being closed based on the information currently available.If the restrictions are lifted or additional information otherwise becomes available, this complaint will be re-opened and re-evaluated.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|